ALEXANDRIA, Va., May 20 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'XIDMI' in its latest official gazette. The trademark application with the serial number 99446216 was filed on Oct. 16, 2025.
Here are the other related details:
Goods and Services: 5 - Pharmaceutical preparations for the treatment and prevention of autoimmune, immune-mediated, immune-system related, inflammatory, and neurological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of rare autoimmune, rare immune-mediated, rare...
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Sanofi 46 avenue de la Grande Armée Paris FR France 75017 99 Corporat...